- Home
- GERN vs HUYA Comparison
GERN vs HUYA Comparison
Compare GERN & HUYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- HUYA
- Stock Information
- Founded
- GERN 1990
- HUYA 2014
- Country
- GERN United States
- HUYA China
- Employees
- GERN N/A
- HUYA 1345
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- HUYA Computer Software: Programming Data Processing
- Sector
- GERN Health Care
- HUYA Technology
- Exchange
- GERN Nasdaq
- HUYA Nasdaq
- Market Cap
- GERN 878.9M
- HUYA 707.2M
- IPO Year
- GERN 1996
- HUYA 2018
- Fundamental
- Price
- GERN $1.27
- HUYA $3.34
- Analyst Decision
- GERN Buy
- HUYA Buy
- Analyst Count
- GERN 11
- HUYA 4
- Target Price
- GERN $5.80
- HUYA $5.68
- AVG Volume (30 Days)
- GERN 15.1M
- HUYA 2.7M
- Earning Date
- GERN 05-07-2025
- HUYA 05-12-2025
- Dividend Yield
- GERN N/A
- HUYA 75.26%
- EPS Growth
- GERN N/A
- HUYA N/A
- EPS
- GERN N/A
- HUYA N/A
- Revenue
- GERN $76,994,000.00
- HUYA $832,858,160.00
- Revenue This Year
- GERN $208.83
- HUYA $3.32
- Revenue Next Year
- GERN $57.49
- HUYA $3.66
- P/E Ratio
- GERN N/A
- HUYA N/A
- Revenue Growth
- GERN 32386.92
- HUYA N/A
- 52 Week Low
- GERN $1.19
- HUYA $2.82
- 52 Week High
- GERN $5.34
- HUYA $6.84
- Technical
- Relative Strength Index (RSI)
- GERN 34.43
- HUYA 48.48
- Support Level
- GERN $1.17
- HUYA $2.85
- Resistance Level
- GERN $1.39
- HUYA $3.38
- Average True Range (ATR)
- GERN 0.13
- HUYA 0.18
- MACD
- GERN 0.01
- HUYA 0.04
- Stochastic Oscillator
- GERN 21.74
- HUYA 91.59
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About HUYA HUYA Inc. American depositary shares each representing one ordinary share
Established in 2011, Huya is the largest online game livestreaming company in China. Headquartered in Guangzhou, Huya mainly provides livestreamed videos on esports games such as League of Legends and Honor of Kings and collects virtual tips from viewers. Its products include the Huya Live platform in China and Nimo TV in Southeast Asia and South America. As of 2023, Huya was a subsidiary of Tencent, which owned 63% of its equity stake and held 94% of the voting power.